Lytix Biopharma AS (DE:6BG) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Lytix Biopharma AS is set to unveil its Q2 2024 financial results in a live webcast on August 29, 2024, featuring insights from CEO Øystein Rekdal and CFO Gjest Breistein. The Norwegian immuno-oncology leader invites questions in advance for the subsequent Q&A session and will provide access to a recorded version of the presentation on their website.
For further insights into DE:6BG stock, check out TipRanks’ Stock Analysis page.
